FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone FDA OKs Somapacitan (Sogroya), First Once-Weekly Growth Hormone

Somapacitan is a human growth hormone analog administered once-weekly by subcutaneous injection to treat adult growth hormone deficiency.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Alert Source Type: news